Immunomodulatory asthma therapy in the equine animal model: A dose‐response study and evaluation of a long‐term effect
Abstract Introduction Equine asthma represents a naturally occurring animal model for human allergic neutrophilic asthma. Inhalative nanoparticle‐bound cytosine‐phosphate‐guanosine (CpG‐GNP) immunotherapy, independent of specific allergens, has already shown promising clinical and immunological resu...
Main Authors: | John Klier, Carolin Bartl, Sabine Geuder, Katharina J. Geh, Sven Reese, Lutz S. Goehring, Gerhard Winter, Heidrun Gehlen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.252 |
Similar Items
-
A comparison of nanoparticulate CpG immunotherapy with and without allergens in spontaneously equine asthma‐affected horses, an animal model
by: John Klier, et al.
Published: (2018-03-01) -
The Dynamics of Circulating Immune Complexes in Horses with Severe Equine Asthma
by: Malwina Slowikowska, et al.
Published: (2021-04-01) -
Omalizumab Treatment in Patients with Severe Allergic Asthma
by: Tuğba Songül Tat, et al.
Published: (2017-09-01) -
Well Known and Unknown Asthma Phenotype: Allergic Asthma
by: Ayse Bilge Öztürk, et al.
Published: (2019-07-01) -
The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data
by: Andrew Briggs, et al.
Published: (2021-01-01)